English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Infections due to antibiotic-resistant Gram-negative bacteria unquestionably have substantial effects on morbidity and mortality. However, quantifying the exact economic burden attributable to these infections still remains a challenging issue. The review of the literature on this subject shows that severe infections from Gram-negative bacteria are associated with increased economic burden. However, the low comparability of methods and results limit the possibility to draw a clear conclusion. A better collaboration between health economy and clinical research is advocated to produce specific guidelines for economic studies in medical research.

Burden of Antibiotic Resistant Gram Negative Bacterial Infections: Evidence and Limits